REKOM BIOTECH appears in IDEAL newspaper
1/12/2020
REKOM BIOTECH appears in the newspaper IDEAL GRANADA in January 12th, 2020. In this article, IDEAL showed to its readers who is Rekom Biotech and Dr. Ana Camacho, CEO of the company, talked about us.
CATEGORY: PRESS
TOPICS OF INTEREST
HIGHLIGHTS
- The IDEA Agency grants Rekom Biotech an incentive to develop new recombinant antigens for the detection of Dengue
- REKOM BIOTECH implements the ISO 13485 standard
- Rekom Biotech is listed as one of the top ten leading vendors in the Insight Partners' Viral Antigens Market Forecast to 2027 report
- Vaccination vs Natural infection. A diagnostic challenge in COVID-19 asymptomatic patients, when the immunity profile is not known.
- Why choose a recombinant antigen?
